| Financial Year |
March 31 2023 |
| Monetary Funds |
112,507,455.51 |
| Held-for-trading Financial Assets |
358,466,036.06 |
| Notes Receivable |
1,010,210.86 |
| Accounts Receivable |
53,005,665.23 |
| Advances to Suppliers |
46,129,448.54 |
| Other Receivables |
622,055,184.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
233,200,058.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,657,375.21 |
| Total Current Assets |
1,433,031,434.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
693,714,815.63 |
| Investment Properties |
-- |
| Fixed Assetes |
1,801,189,508.02 |
| Under-construction Projects |
628,199,680.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
523,044,176.03 |
| R&D expenses |
-- |
| Goodwill |
38,489,025.76 |
| Long-Term Deferred and Prepaid Expenses |
34,744,761.65 |
| Deferred Income Tax Assets |
23,897,669.22 |
| Other Non-Current Assets |
42,478,097.92 |
| Sub-Total of Non-Current Assets |
3,825,312,412.66 |
| Total Assets |
5,258,343,847.05 |
| Short-Term Loans |
522,194,467.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,042,273.96 |
| Accounts Payable |
152,936,533.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,684,537.52 |
| Taxes Payable |
21,495,644.37 |
| Interest Payable |
-- |
| Dividend Payable |
8,334,000.00 |
| Other payables |
99,122,705.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
421,410,417.18 |
| Other Current Liabilities |
10,722,295.70 |
| Sub-Total of Current Liabilities |
1,363,213,951.97 |
| Long-term Loans |
128,303,640.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
57,206,450.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
134,789,700.00 |
| Deferred Income Tax Liabilities |
16,185,560.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
349,988,291.45 |
| Total Liabilities |
1,713,202,243.42 |
| Paid-In Capital(Or Share Stock) |
128,674,022.00 |
| Capital Surplus |
452,139,815.51 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,707,980,551.01 |
| Minority Stockholder's Interest |
551,632,725.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,993,508,878.32 |
| Owner's Equity（Stockholder's Equity） |
3,545,141,603.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,258,343,847.05 |
